葉酸靶向紫杉醇聚合物納米囊泡的制備及其抗腫瘤活性研究-資料下載頁(yè)
2025-01-15 01:46本頁(yè)面
【正文】 the Development of Paclitaxel Formulation [J]. Chin Pharm J (中國(guó)藥學(xué)雜志), 2006, 41(18): 13661370.[4] WEISS R B, DONEHOWER R C, WIERNIK P H. Hypersensitivity reactions from Taxol [J]. J Clin Oncol, 1990, 8 (7):12631268.[5] MA G L, SONG C X. PCL/poloxamer 188 blend microsphere for paclitaxel delivery: influence of poloxamer 188 onmorphology and drug release [J]. Appl. Polym. Sci, 2007, 104: 18951899.[6] YANG T, CHOI M K. Preparation and evaluation of Paclitaxelloaded PEGylated immunoliposome [J]. J Control Release, 2007, 120:169177[7] ZHANG Z, FENG S S. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of Paclitaxelloaded poly (lactide)tocopheryl polyethylene glycol succinate nanoparticles [J]. Biomaterials, 2006, 27:40254033.[8] HUH K M, MIN H S, CHEONLEE S, et al. A new hydrotopic block copolymer micelle system for aqueous solubilization of Paclitaxel [J]. J Control Release, 2008, 126:122129.[9] DANHIER F, LECOUTURIER N, VROMAN B, et al. Paclitaxelloaded PEGylated PLGAbased nanoparticles: In vitro and in vivo evaluation [J]. J Control Release, 2009, 133(1):1117. [10] XIE Z G, GUAN, H L, CHEN X S, et al. A novel polymer–paclitaxel conjugate based on amphiphilic triblock copolymer [J]. J Control Release, 2007, 117:210216.[11] OOYA T, LEE J, PARK K. Effects of ethylene glycolbased graft, starshaped, and dendritic polymers on solubilization and controlled release of paclitaxel [J]. J Control Release, 2003, 93: 121127.[12] LETCHFORD K, BURT H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes [J]. Eur J Pharm Biopharm, 2007, 65(3):259269.[13] SINGH R, LILLARD J W. Nanoparticlebased targeted drug delivery [J]. Exp Mol Pathol, 2009, 86(3):215223.[14] LEVINE D H, GHOROGHCHIAN P P, FREUDENBERG J, et al. Polymersomes: a new multifunctional tool for cancer diagnosis and therapy [J]. Methods, 2008, 46(1): 2532.[15] MENG F, HIEMSTRA C, ENGBERS G H M, et al. Biodegradable Polymersomes [J]. Macromol, 2003, 36(9):30043006.[16] GRUNER B A, WEITMAN S D. The folate receptor as a potential therapeutic anticancer target [J]. Invest New Drugs, 1999, 16: 205219.[17] LU Y, LOW P S. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors [J]. Cancer Immunol. Immunother, 2002, 51:153162.[18] LEAMON C P, LOW P S. Folatemediated targeting: from diagnostics to drug and gene delivery [J]. Drug Discov Today, 2001, 6(1):4451.[19] PATLOLLA R R, VOBALABOINA V J. Folatetargeted etoposideencapsulated lipid nanospheres [J]. Drug Target, 2008, 16(4):269275.[20] CHAN J M, ZHANG L, YUET K P, et al. PLGAlecithinPEG coreshell nanoparticles for controlled drug delivery [J]. Biomaterials, 2009, 30(8):16271634. [21] CHO Y W, LEE J, LEE S C, et al. Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles [J]. J Control Release, 2004, 97:249257.
公司管理相關(guān)推薦
鄂ICP備17016276號(hào)-1